Audited Supplier
QS-Glycopyrrolate
596-51-0
C19h28brno3
209-887-0
Negotiable
Normal
>12 Months
Glycopyrrolate
Glycopyrrolate
>99%
Glycopyrrolate
Glycopyrrolate Bromide
White Powder
White
99%
HPLC
C19h28brno3
398.335
193-194.5 Oc
488.0 Oc at 760 Mmhg
Pharmaceutical
Pharmaceutical
1.3222
1.6200
H2O: >24mg/Ml
QS
Negotiable
negotiable
Xi'an
Product Description
Factory Supply Glycopyrrolate Bromide Pharmaceutical Glycopyrrolate
| Product name | Glycopyrrolate |
| Cas number | 596-51-0 |
| Appearance | White Powder |
| MF | C19H28BrNO3 |
| MW | 398.335 |
1. Inhibit glandular secretion: Glononium bromide can block the M choline receptor on the gland, thereby reducing the secretion of salivary glands, sweat glands, respiratory glands, etc. The use before surgery can reduce saliva secretion, prevent the risk of aspiration caused by excessive saliva during the operation, and keep the respiratory tract relatively dry, which is conducive to surgical operation and patient safety.
2. Relax gastrointestinal smooth muscle: It can act on choline receptors on smooth muscle cells of the gastrointestinal tract to relax smooth muscle. It is helpful to relieve gastrointestinal spasm, relieve abdominal pain, abdominal distension and other uncomfortable symptoms, and has a certain therapeutic effect on gastrointestinal spasmodic diseases.
3. Increase heart rate: By blocking the M choline receptor, the inhibitory effect of the vagus nerve on the heart can be lifted, thereby increasing the heart rate. In some cases of bradycardia, it may play a role in improving the heart rate.
4. Treatment of gastrointestinal diseases: The relaxation effect of glontium on gastrointestinal smooth muscle and the inhibition of glandular secretion have certain value in the treatment of some gastrointestinal diseases. For example, for gastroesophageal reflux, reducing gastric acid secretion and glandular secretion associated with lower esophageal sphincter relaxation, while relaxing gastrointestinal smooth muscle, can help reduce reflux symptoms.
